Karyopharm Therapeutics Inc.
KPTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$76,422 | -$143,099 | -$165,291 | -$124,088 |
| Dep. & Amort. | $340 | $530 | $621 | $789 |
| Deferred Tax | $0 | $0 | $0 | $1,454 |
| Stock-Based Comp. | $18,426 | $21,709 | $35,399 | $29,783 |
| Change in WC | -$302 | $31,415 | -$19,989 | -$23,189 |
| Other Non-Cash | -$69,528 | -$3,278 | -$294 | $8,135 |
| Operating Cash Flow | -$127,486 | -$92,723 | -$149,554 | -$107,116 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$142 | $0 | -$118 | -$5,712 |
| Net Acquisitions | $0 | $0 | $104,256 | $5,500 |
| Inv. Purchases | -$58,822 | -$159,151 | -$226,016 | -$45,228 |
| Inv. Sales/Matur. | $154,437 | $167,091 | $121,878 | $192,780 |
| Other Inv. Act. | $0 | $0 | -$104,256 | -$5,500 |
| Investing Cash Flow | $95,473 | $7,940 | -$104,256 | $141,840 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $83,300 | $0 | $0 | $60,000 |
| Stock Issued | $1,452 | $1,124 | $189,761 | $9,903 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$43,106 | $0 | $3,977 | $3,745 |
| Financing Cash Flow | $41,646 | $1,124 | $193,738 | $73,648 |
| Forex Effect | -$11 | -$34 | -$488 | -$48 |
| Net Chg. in Cash | $9,622 | -$83,693 | -$60,560 | $108,324 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,192 | $136,885 | $197,445 | $89,121 |
| End Cash | $62,814 | $53,192 | $136,885 | $197,445 |
| Free Cash Flow | -$127,628 | -$92,723 | -$149,672 | -$112,828 |